For: | Shah B, Shah G. Antifibrotic effect of heparin on liver fibrosis model in rats. World J Gastrointest Pharmacol Ther 2012; 3(6): 86-92 [PMID: 23494756 DOI: 10.4292/wjgpt.v3.i6.86] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v3/i6/86.htm |
Number | Citing Articles |
1 |
Dan Liu, Qi Yu, Zibo Li, Lin Zhang, Ming Hu, Caiyan Wang, Zhongqiu Liu. UGT1A1 dysfunction increases liver burden and aggravates hepatocyte damage caused by long-term bilirubin metabolism disorder. Biochemical Pharmacology 2021; 190: 114592 doi: 10.1016/j.bcp.2021.114592
|
2 |
AMAL HASSANIN, HALA ABDEL MALEK, DALIA SALEH. Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitis. Experimental and Therapeutic Medicine 2014; 8(5): 1551 doi: 10.3892/etm.2014.1963
|
3 |
Mi Na Gil, Du Ri Choi, Kwang Sik Yu, Ji Heun Jeong, Dong-Ho Bak, Do-Kyung Kim, Nam-Seob Lee, Je-Hun Lee, Young-Gil Jeong, Chun Soo Na, Dae Seung Na, Ki-Hyun Ryu, Seung Yun Han. Rhus vernicifluaStokes attenuates cholestatic liver cirrhosis-induced interstitial fibrosis via Smad3 down-regulation and Smad7 up-regulation. Anatomy & Cell Biology 2016; 49(3): 189 doi: 10.5115/acb.2016.49.3.189
|
4 |
José Ignacio Fortea, Ángela Puente, Antonio Cuadrado, Patricia Huelin, Raúl Pellón, Francisco José González Sánchez, Marta Mayorga, María Luisa Cagigal, Inés García Carrera, Marina Cobreros, Javier Crespo, Emilio Fábrega. Congestive Hepatopathy. International Journal of Molecular Sciences 2020; 21(24): 9420 doi: 10.3390/ijms21249420
|
5 |
Aya Mohammed, Ekram N Abd Al Haleem, Wesam M El‐Bakly, Ebtehal El‐Demerdash. Deferoxamine alleviates liver fibrosis induced by CCl4 in rats. Clinical and Experimental Pharmacology and Physiology 2016; 43(8): 760 doi: 10.1111/1440-1681.12591
|
6 |
Jose Ignacio Fortea, Ángela Puente, Antonio Cuadrado, Patricia Huelin, Inés García, Marta Mayorga, Raul Pellon, Javier Crespo, Emilio Fábrega. Liver Pathology. 2021; doi: 10.5772/intechopen.89177
|
7 |
Maha G. Elfeky, Eman M. Mantawy, Amany M. Gad, Hala M. Fawzy, Ebtehal El-Demerdash. Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways. Life Sciences 2020; 240: 117096 doi: 10.1016/j.lfs.2019.117096
|